Search for: "AMGEN INC. v. PRICE et al"
Results 1 - 20
of 25
Sort by Relevance
|
Sort by Date
25 Jan 2024, 6:32 am
The FTC also touted its settlement of the Amgen/Horizon matter (here and here) although, as I explained in December, the core of the consent order—reached on the eve of trial—had been proposed by Amgen all along. [read post]
31 Dec 2023, 4:29 pm
Goldsmith et al. [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
12 Apr 2021, 5:55 am
On March 29, the United States Supreme Court heard oral argument in Goldman Sachs Group, Inc., et al. v. [read post]
10 Sep 2020, 3:00 am
In Immunex Corp. et al. v. [read post]
2 Jan 2019, 10:26 am
Delta Airlines Inc., et al., the 11th Circuit noted that, “while Fifth Third may have changed the legal analysis of our prior decision, it does not alter the outcome. [read post]
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am
Sleet in Genentech, Inc. et al. v. [read post]
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
12 Apr 2017, 5:00 am
Doe et al., No. 16-222-cv, 2016 BL 292694 (2d Cir. [read post]
12 Jan 2017, 7:01 am
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
9 Oct 2013, 4:30 am
Amgen Inc., et al., 2013 U.S. [read post]
12 Mar 2013, 8:03 am
Amgen Inc., et al. v. [read post]
18 Nov 2011, 6:58 am
Amgen et al., it was also the basis for a securities lawsuit alleging that a retirement investor was misled by public statements made by Amgen Inc. and four of its officers about the anemia drugs Aranesp and Epogen. [read post]
12 Oct 2011, 11:56 am
Amgen, Inc. et al., No. 1:06-cv-10972-WGY, (D. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
13 May 2009, 8:00 pm
Amgen Inc. v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
